In trading on Tuesday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Clovis Oncology ( CLVS ), up about 8.6% and shares of Karyopharm Therapeutics ( KPTI ), up about 8.4% on the day.
And underperforming other ETFs today is the Gold Miners ETF ( GDX ), off about 1.5% in Tuesday afternoon trading. Among components of that ETF with the weakest showing on Tuesday were shares of First Majestic Silver ( AG ), lower by about 5%, and shares of Gold Fields (GFI), lower by about 3.1% on the day.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
